Resistance to carbapenems is emerging, and it is a great problem to therapeutics. Three isolates of Pseudomonas aeruginosa from a Portuguese hospital identified in urine and sputum, in 1995, presented a high-level resistance to imipenem (32 mg/L). Afterward, one isolate of P. aeruginosa recovered from urine of an ambulatory patient in 1998 showed high resistance to imipenem. and meropenem. The resistance to carbapenems in these strains was associated with the production of a class B beta-lactamase, as was demonstrated by imipenem hydrolysis and inhibition by EDTA. Using primers described for bla(IMP) and bla(VIM) the amplification of the latter was observed in all isolates and a VIM-2 metallo-enzyme was identified. The pulsed-field gel elec...
Pseudomonas aeruginosa is one of the most frequently isolated Gram-negative pathogens associated wit...
The prevalence of imipenem resistance among Pseudomonas aeruginosa isolates at a 195-bed tertiary ca...
Since about twenty years, following the introduction into therapeutic of news beta-lactam antibiotic...
Resistance to carbapenems is emerging, and it is a great problem to therapeutics. Three isolates of ...
The aim of this investigation was to characterize metallo-β-lactamases (MBLs) in Pseudomonas aerugin...
ABSTRACTPseudomonas aeruginosa isolates (n = 183), collected from bacteraemic patients hospitalised ...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
Out of 24 nosocomial strains of Pseudomonas aeruginosa from Recife, Brazil, 15 (62%) were metallo-β-...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
Background: Pseudomonas aeruginosa is the causing agent of many hospital infections and metallo-beta...
Carbapenems are therapeutic choice against infections caused by Gram-negative bacilli including stra...
peer reviewedThe prevalence and the type(s) of metallo-β-lactamases (MBLs) produced by isolates of P...
Pseudomonas aeruginosa is one of the most frequently isolated Gram-negative pathogens associated wit...
The prevalence of imipenem resistance among Pseudomonas aeruginosa isolates at a 195-bed tertiary ca...
Since about twenty years, following the introduction into therapeutic of news beta-lactam antibiotic...
Resistance to carbapenems is emerging, and it is a great problem to therapeutics. Three isolates of ...
The aim of this investigation was to characterize metallo-β-lactamases (MBLs) in Pseudomonas aerugin...
ABSTRACTPseudomonas aeruginosa isolates (n = 183), collected from bacteraemic patients hospitalised ...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
Out of 24 nosocomial strains of Pseudomonas aeruginosa from Recife, Brazil, 15 (62%) were metallo-β-...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
The prevalence and the type(s) of metallo-beta-lactamases (MBLs) produced by isolates of Pseudomonas...
Background: Pseudomonas aeruginosa is the causing agent of many hospital infections and metallo-beta...
Carbapenems are therapeutic choice against infections caused by Gram-negative bacilli including stra...
peer reviewedThe prevalence and the type(s) of metallo-β-lactamases (MBLs) produced by isolates of P...
Pseudomonas aeruginosa is one of the most frequently isolated Gram-negative pathogens associated wit...
The prevalence of imipenem resistance among Pseudomonas aeruginosa isolates at a 195-bed tertiary ca...
Since about twenty years, following the introduction into therapeutic of news beta-lactam antibiotic...